Diffusion tensor cardiovascular magnetic resonance differentiates pediatric dilated and hypertrophic cardiomyopathies

Jaime Torres Juárez1, Silvia Hidalgo Tobón2, Sergio Alfonso Patrón Chi3

  • 1Universidad Autónoma Metropolitana - Iztapalapa, 09310 Mexico City, Mexico.

Insights

Diffusion tensor imaging (DTI) reveals distinct microstructural differences in pediatric dilated and hypertrophic cardiomyopathies. These quantitative metrics, apparent diffusion coefficient (ADC) and fractional anisotropy (FA), correlate with ventricular function and aid in diagnosis.

Area of Science:

  • Cardiovascular Imaging
  • Biomedical Engineering
  • Pediatric Cardiology

Background:

  • Pediatric cardiomyopathies are myocardial diseases with high morbidity and mortality.
  • Conventional cardiovascular magnetic resonance (CMR) lacks insight into myocardial microstructure.
  • Diffusion tensor imaging (DTI) assesses microstructure via apparent diffusion coefficient (ADC) and fractional anisotropy (FA).

Purpose of the Study:

  • To evaluate DTI's utility in differentiating pediatric dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM).
  • To analyze quantitative ADC and FA metrics for distinct microstructural biomarkers.
  • To correlate DTI metrics with ventricular function, specifically left ventricular ejection fraction (LVEF).

Main Methods:

  • Mixed retrospective-prospective study of 21 pediatric cardiomyopathy patients and 11 healthy volunteers.
  • Cardiac DTI performed on a 3T MRI system with a free-breathing, motion-compensated protocol.
  • Quantitative ADC and FA analysis in the interventricular septum, with statistical comparisons and ROC curve generation.

Main Results:

  • Significant differences in ADC and FA were observed among healthy, DCM, and HCM groups (p < 0.001).
  • DCM showed highest ADC and lowest FA; HCM had moderately elevated ADC with preserved FA.
  • ADC and FA correlated significantly with LVEF (p < 0.001) and demonstrated excellent/good discriminatory performance for DCM and HCM identification.

Conclusions:

  • Cardiac DTI-derived ADC and FA metrics reveal distinct microstructural patterns in pediatric cardiomyopathies.
  • These DTI metrics show significant associations with ventricular function.
  • DTI offers complementary quantitative biomarkers for myocardial characterization in pediatric populations, requiring further validation.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...